Strand

Strand Life Sciences Pvt Ltd. is a clinical diagnostics and genomic profiling company based in Bengaluru, India, specializing in the development and marketing of diagnostic tests for cancer and inherited diseases. Founded in 2000, the company offers a wide range of services, including diagnostics for oncology, genetics, fertility, women's health, infectious diseases, and general wellness. Strand provides advanced bioinformatics solutions, such as variant curation and interpretation platforms, along with its StrandOmics software for actionable insights from genomic data. The firm operates a DNA sequencing lab and has established partnerships with over 100 hospitals in India, expanding its reach into the US market. Strand's innovative software, including GeneSpring and Avadis, is utilized by 1,400 research institutions worldwide. The company emphasizes personalized medicine by identifying hereditary cancer risks and enabling tailored surveillance and risk-reduction strategies for patients. With a team of approximately 200 employees, Strand Life Sciences continues to grow in response to increasing demand for its genomic testing and interpretation services.

Karishma Maini

Vice President, Clinical Business

Prabhakar Rajagopal Ph.D

Senior Vice President, Biodiversity Informatics and Director

2 past transactions

Quest Diagnostics India

Acquisition in 2018
Quest Diagnostics India is a prominent provider of pathology and clinical laboratory testing services, facilitating informed healthcare decisions for physicians and healthcare professionals. The company conducts a wide range of diagnostic tests, including cancer and infectious disease testing, with capabilities to handle specialized tests such as those for the chikungunya virus. Its central laboratory, located in Gurugram, Delhi, supports clinical trials and enhances the company's ability to deliver critical health information. By consistently introducing innovative tests and technologies, Quest Diagnostics India has established itself as a leader in the clinical laboratory sector, helping to improve patient care through reliable and timely diagnostics.

Triesta Sciences

Acquisition in 2018
Triesta Sciences Inc. is a molecular diagnostics company specializing in oncology, based in Bengaluru, India. Founded in 2002, it offers a comprehensive suite of laboratory testing services for cancer diagnosis, including genomic biomarker research and translational research. The company provides a range of analytical and diagnostic services across various fields such as pharmacology, toxicology, immunology, biochemistry, microbiology, and viral serology. Triesta Sciences also supports pharmaceutical and biotechnology companies through research and development services that encompass clinical trial management and biomarker discovery and validation. As of February 2018, the company operates as a subsidiary of Strand Life Sciences Pvt Ltd.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.